<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although not the sole factor, <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-mediated excitotoxicity is accepted as a major mechanism of ischemic neuronal damage </plain></SENT>
<SENT sid="1" pm="."><plain>MK-801 and mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo>, two cerebroprotective modalities, which have been documented to alter glutamatergic action, were tested in the rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model simulating permanent focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We administered normothermic (37 degrees C) animals with either MK-801 (1.0 mg/kg 30 min before MCAO or 2.5 mg/kg 30 min before, immediately after, 4 hours, and 8 hours after MCAO) or saline vehicle (30 min before MCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>Mildly hypothermic (33 degrees C) animals were administered either MK-801 (1.0 mg/kg) or saline vehicle 30 minutes before MCAO </plain></SENT>
<SENT sid="4" pm="."><plain>Mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> was induced over a 20-minute period before MCAO in hypothermic animals </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> animals were killed 24 hours after MCAO; their brains were sectioned and stained with 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> and their <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were calculated </plain></SENT>
<SENT sid="6" pm="."><plain>In normothermica animals given 1.0 mg/kg and multidose 2.5-mg/kg intraperitoneal injections of MK-801, the <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes (as a percentage of right hemispheric volume) were 16.8 +/- 3.5% and 16.3 +/- 3.0%, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>These <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were significantly different (P &lt; 0.05; single-variable analysis of variance) from the normothermic, drug-free control (26.8 +/- 1.9%), but not significantly different from each other </plain></SENT>
<SENT sid="8" pm="."><plain>Analysis of the data using a nonparametric test (Kruskal-Wallis; P = 0.02) confirmed the same significant differences in <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="9" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes from the mildly hypothermic groups were not different (1 mg/kg of MK-801, 15.5 +/- 2.3% and saline control, 15.4 +/- 1.1%).(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>